Succinylcholine
- Inducing Paralysis
- Neuromuscular Blocking Drugs
- Motor Nicotinic Receptor
- ACh Receptor Agonist
- Depolarization
- Phase I (Paralysis Non-reversible)
- Phase II (Paralysis Reversible)
- Neostigmine (Reversal Agent)
Nondepolarizing Neuromuscular Blocking Drugs
- Names Include "Cur"
- Competitive Antagonists
- Acetylcholine Competition
- Reversal of Blockade
- Neostigmine, Edrophonium
Opioids Overview
- Pain
- Weaning
- Cough
- Diarrhea
- Agonists at Mu (μ), Kappa (Κ), and Delta (δ) Receptors
- Decrease Synaptic Transmission
- Respiratory Depression
- Addiction
- Miosis
- Constipation
Malignant Hyperthermia vs. Neuroleptic Malignant Syndrome vs. Serotonin Syndrome
- Autonomic Instability
- Muscle Rigidity
- Ryanodine Receptor 1 Mutation
- Inhaled Anesthetics
- Succinylcholine
- Dantrolene
- Antidopaminergic Medications
- Hyporeflexia
- Myoglobinuria
- Dantrolene
- Serotonergic Medications
- Hyperreflexia
- Clonus
- Cyproheptadine
Cyclobenzaprine (Flexeril)
- Centrally-Acting Muscle Relaxer
- Act on Alpha and Gamma Motor Neurons
- Related to Tricyclic Antidepressants (TCAs)
- Muscle Spasms
- Back Pain
- MAO Inhibitors
- Serotonin Syndrome
- Drowsiness
- Arrhythmia
Baclofen
- GABA-B Receptor Agonist
- Spinal Cord
- Spasticity
- Dystonia
- Multiple Sclerosis
- CNS Depression
- Nausea
- Taper Gradually
Fentanyl
- Opioid Receptor Agonist
- High Potency
- Anesthesia Induction
- Chronic Pain
- Breakthrough Pain
- CNS Depression
- Respiratory Depression
- Constipation
- Miosis
- Addiction
Buprenorphine-Naloxone (Suboxone)
- Combination Drug
- Partial Opioid Receptor Agonist (Buprenorphine)
- Opioid Receptor Antagonist (Naloxone)
- Opioid Use Disorder
- CNS Depression
- Diaphoresis
- Hypotension
- Low Abuse Potential